Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
November-2017 Volume 14 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2017 Volume 14 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Coexistence of p210BCR‑ABL and CBFβ‑MYH11 fusion genes in myeloid leukemia: A report of 4 cases

  • Authors:
    • Yuan‑Yuan Wang
    • Wen‑Jing Ding
    • Feng Jiang
    • Zi‑Xing Chen
    • Jian‑Nong Cen
    • Xiao‑Fei Qi
    • Jian‑Ying Liang
    • Dan‑Dan Liu
    • Jin‑Lan Pan
    • Su‑Ning Chen
  • View Affiliations / Copyright

    Affiliations: Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, Jiangsu 215006, P.R. China, Central Hospital of Zibo, Zibo, Shandong 255036, P.R. China, The Second People's Hospital of Chizhou, Chizhou, Anhui 247100, P.R. China
    Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 5171-5178
    |
    Published online on: August 24, 2017
       https://doi.org/10.3892/ol.2017.6812
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Numerous acquired molecular and cytogenetic abnormalities are strongly associated with hematological malignancies. The breakpoint cluster region‑ABL proto‑oncogene 1 (BCR‑ABL) rearrangement leads to a p210 chimeric protein in typical chronic myeloid leukemia (CML), whereas 17‑25% of patients with acute lymphocytic leukemia and 0.9‑3% patients with de novo acute myeloid leukemia (AML) carry a p190BCR‑ABL fusion protein. Cases of patients with AML/CML carrying two specific primary molecular changes, BCR‑ABL and core binding factor‑β‑myosin heavy chain 11 (CBFβ‑MYH11) fusion genes have been rarely reported. The present study aimed to understand the nature and mechanism of this particular type of leukemia through case reports and literature review. A total of four patients who were diagnosed as AML/CML with BCR‑ABL and CBFβ‑MYH11 fusion genes in the First Affiliated Hospital of Soochow University (Suzhou, China) between January 2004 and December 2012 were examined. Morphological analysis of bone marrow cells, flow cytometry, quantitative polymerase chain reactionof p210BCR‑ABL and CBFβ‑MYH11 transcripts as well as cytogenetic and fluorescence in situ hybridization analyses were performed. A total of 4 patients who exhibited fusion of p210BCR‑ABL and CBFβ‑MYH11 were identified. A single patient (case 1) was first diagnosed CML‑acute phase (AP), which progressed rapidly to CML‑blast crisis (BC), and three patients (cases 2, 3 and 4) were diagnosed with AML with bone marrow eosinophilia at first presentation with no evidence of previous onset of CML. All cases achieve dremission following conventional chemotherapy/hematological stem cell transplantation combined with the inhibitor of tyrosine kinase (TKI) maintenance therapy. The patients with CML carrying and expressing BCR‑ABL and CBFβ‑MYH11 fusion genes appeared more likely to rapidly progress to AP or BC. Therefore, the product of the CBFβ‑MYH11 fusion gene may serve an important role in the transformation of CML. The co‑expression of p210BCR‑ABL and CBFβ‑MYH11 fusion genes in myeloid leukemia may be a molecular event occurring not only during the development of CML, but also in AML.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Cividin M, Brizard F, Sorel N, Renaud M, Guilhot F and Brizard A: p190(BCR-ABL) rearrangement as a secondary change in a case of acutenmyelo-monocytic leukemia with inv(16)(p13q22). Leuk Res. 28:97–99. 2004. View Article : Google Scholar : PubMed/NCBI

2 

Delaunay J, Vey N, Leblanc T, Fenaux P, Rigal-Huguet F, Witz F, Lamy T, Auvrignon A, Blaise D, Pigneux A, et al: Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup. Blood. 102:462–469. 2003. View Article : Google Scholar : PubMed/NCBI

3 

Liu P, Tarlé SA, Hajra A, Claxton DF, Marlton P, Freedman M, Siciliano MJ and Collins FS: Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science. 261:1041–1044. 1993. View Article : Google Scholar : PubMed/NCBI

4 

Kundu M and Liu PP: Function of the inv(16) fusion gene CBFB-MYH11. Current Opinion in Hematology. 8:2012001. View Article : Google Scholar : PubMed/NCBI

5 

Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J and Vardiman JW: WHO classification of tumors of hematopoietic and lymphoid tissues. 4th. IARC WHO Classification of Tumours; Lyon: 2008

6 

Nowell PC and Hungerford DA: A minute chromosome in human chronic granulocytic leukemia. Science. 142:14971960.

7 

Rowley JD: Letter: a new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature. 243:290–293. 1973. View Article : Google Scholar : PubMed/NCBI

8 

Faderl S, Talpaz M, Kantarjian HM and Estrov Z: Should polymerase chain reaction analysis to detect minimal residual disease in patients with chronic myelogenous leukemia be used in clinical decision making? Blood. 93:2755–2759. 1999.PubMed/NCBI

9 

World Health Organization Classification of Tumours: Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Jaffe ES, Harris NL, Stein H and Vardiman JW: IARC WHO Classification of Tumours; Lyon: pp. 3522001

10 

Keung YK, Beaty M, Powell BL, Molnar I, Buss D and Pettenati M: Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia-retrospective study and review of literature. Leuk Res. 28:579–586. 2004. View Article : Google Scholar : PubMed/NCBI

11 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

12 

Cheung SW, Crane JP and Burgess AC: High resolution R banding in amniotic fluid cells using the BrdU-Hoechst 33258-Giemsa (RBG) technique. Human Genetics. 69:86–87. 1985. View Article : Google Scholar : PubMed/NCBI

13 

Shaffer LG, Slovak ML and Campbell LJ: International Standing Committee on Human Cytogenetic Nomenclature: ISCN 2009: An international system for human cytogenetic nomenclature. Shaffer LG, Slovak ML and Campbell LJ: Karger Publishers; Switzerland: 2009

14 

Li X, Li X, Xie W, Hu Y, Li J, Du W, Liu W, Li H, Chen X, Zhang L, et al: Comprehensive profile of cytogenetics in 2308 Chinese children and adults with de novo acute myeloid leukemia. Blood Cells Mol Dis. 49:107–113. 2012. View Article : Google Scholar : PubMed/NCBI

15 

Popescu R, Dăscălescu A, Dănăilă C, Ghiorghiu D, Zlei M, Ivanov A, Sireteanu A, Gorduza EV and Azoicăi D: Co-expression of the CBFβ-MYH11 and BCR-ABL fusion genes in chronic myeloid leukaemia. Revista Romana De Medicina De Laborator. 23:221–230. 2015. View Article : Google Scholar

16 

Wu Y, Slovak ML, Snyder DS and Arber DA: Coexistence of inversion 16 and the philadelphia chromosome in acute and chronic myeloid leukemias: Report of six cases and review of literature. Am J ClinPathol. 125:260–266. 2006.

17 

Ninomiya S, Kanemura N, Tsurumi H, Kasahara S, Hara T, Yamada T and Moriwaki H: Coexistence of inversion 16 and the Philadelphia chromosome comprising P190 BCR/ABL in chronic myeloid leukemia blast crisis. Int J Hematol. 93:806–810. 2011. View Article : Google Scholar : PubMed/NCBI

18 

Preudhomme C, Lai JL, Plantier I, Demory JL, Zandecki M and Fenaux P: Cytogenetic and molecular remission in a case of acute myeloid leukemia (AML) with inversion of chromosome 16 (inv(16)) and Philadelphia chromosome (Ph). Br J Haematol. 82:623–626. 1992. View Article : Google Scholar : PubMed/NCBI

19 

Siddiqui AD, Sheikh ZS, Liu D and Seiter K: Coexistence of inversion 16 and the Philadelphia chromosome in patients with acute myelogenous leukemia. Leuk Lymphoma. 43:1137–1140. 2002. View Article : Google Scholar : PubMed/NCBI

20 

Li YS and Hayhoe FG: Ph1 chromosome positive acute myelomonocytic leukemia with inverted chromosome 16. Br J Haematol. 69:5761988. View Article : Google Scholar : PubMed/NCBI

21 

Miura I, Takatsu H, Yamaguchi A, Hashimoto K, Nimura T, Nishinari T, Niitsu H and Miura AB: Standard Ph chromosome t(9;22)(q34;q11), as an additional change in a patient with acute myelomonocytic leukemia (M4Eo) associated with inv(16)(p13q22). AM J Haematol. 45:94–96. 1994. View Article : Google Scholar

22 

Secker-Walker LM, Morgan GJ, Min T, Swansbury GJ, Craig J, Yamada T, Desalvo L, Medina JW, Chowdhury V, Donahue RP, et al: Inversion of chromosome 16 with the Philadelphia chromosome in acute myelomonocytic leukemia with eosinophilia: report of two cases. Cancer Genet Cytogenet. 58:29–34. 1992. View Article : Google Scholar : PubMed/NCBI

23 

Svaldi M, Lanthaler A, Venturi R, Coser P and Mitterer M: Simultaneous occurrence of bcr-abl and inv16 in a case of M1 acute myeloid leukemia. Leukemia. 15:695–699. 2001. View Article : Google Scholar : PubMed/NCBI

24 

Tirado CA, Valdez F, Klesse L, Karandikar NJ, Uddin N, Arbini A, Fustino N, Collins R, Patel S, Smart RL, et al: Acute myeloid leukemia with inv(16) with CBFBMYH11, 3′CBFB deletion, variant t(9;22) with BCR-ABL1 and del(7)(q22q32) in a pediatric patient: case report and literature review. Cancer Genet Cytogenet. 200:54–59. 2010. View Article : Google Scholar : PubMed/NCBI

25 

Roth CG, Contis L, Gupta S, Agha M and Safyan E: De novo acute myeloid leukemia with Philadelphia chromosome (BCR-ABL)and inversion 16(CBFβ-MYH11): report of two cases and review of the literature. Leukemia & Lymphoma. 52:531–535. 2011. View Article : Google Scholar : PubMed/NCBI

26 

Bustamante D, Chan KR, Czuchlewski DR and Saadi AA: Patterns of BCR breakpoints in patients with coexisting inv(16)(p13.1q22) and t(9;22)(q34;q11.2). Int J Hematol. 95:324–326. 2012. View Article : Google Scholar : PubMed/NCBI

27 

Merzianu M, Medeiros LJ, Cortes J, Yin C, Lin P, Jones D, Glassman A, Kantarjian H and Huh Y: inv(16)(p13q22) in Chronic myelogenous leukemia in blast phase: A clinicopathologic, cytogenetic and molecular study of five cases. Am J Clin Pathol. 124:807–814. 2005. View Article : Google Scholar : PubMed/NCBI

28 

Tsuboi K, Komatsu H, Miwa H, Iida S, Banno S, Wakita A, Nitta M and Ueda R: Lymphoid blastic crisis of chronic myelogenous leukemia with inv(16)(p13;q22). Leuk Res. 26:771–774. 2002. View Article : Google Scholar : PubMed/NCBI

29 

Myint H, Ross FM, Hall JL and Hamblin TJ: Early transformation to acute myeloblastic leukemia with the acquisition of inv(16) in Ph positive chronic granulocytic leukemia. Leuk Res. 21:473–474. 1997. View Article : Google Scholar : PubMed/NCBI

30 

Evers JP, Bagg A, Himoe E, Zwiebel JA and Jacobson RJ: Temporal association of marrow eosinophilia with inversion of chromosome 16 in recurrent blast crises of chronic myelogenous leukemia. Cancer Genet Cytogenet. 62:134–139. 1992. View Article : Google Scholar : PubMed/NCBI

31 

Asou N, Sanada I, Tanaka K, Hidaka M, Suzushima H, Matsuzaki H, Kawano F and Takatsuki K: Inversion of chromosome 16 and bone marrow eosinophilia in a myelomonocytic transformation of chronic myeloid leukemia. Cancer Genet Cytogenet. 61:197–200. 1992. View Article : Google Scholar : PubMed/NCBI

32 

Enright H, Weisdorf D, Peterson L, Rydell RE, Kaplan ME and Arthur DC: Inversion of chromosome 16 and dysplastic eosinophils in accelerated phase of chronic myeloid leukemia. Leukemia. 6:381–384. 1992.PubMed/NCBI

33 

Heim S, Christensen BE, Fioretos T, Sørensen AG and Pedersen NT: Acute myelomonocytic leukemia with inv(16)(p13q22) complicating Philadelphia chromosome positive chronic myeloid leukemia. Cancer Genet Cytogenet. 59:35–38. 1992. View Article : Google Scholar : PubMed/NCBI

34 

Colovic M, Jankovic G, Bila J, Djordjevic V and Wiernik PH: Inversion of chromosome 16 in accelerated phase of chronic myeloid leukemia: report of a case and review of the literature. Med Oncol. 15:199–201. 1998. View Article : Google Scholar : PubMed/NCBI

35 

Yin CC, Jones D, Cortes JE, Kantarjian H and Merzianu M: Medeiros LJ and Bueso-Ramos CE: Type B core binding factor β/smooth muscle myosin heavy chain fusion transcript in myeloid blast phase of chronic myeloid leukemia: Correlation with nuclear and cytoplasmic localization of the fusion protein. Clinical Leukemia. 2:257–260. 2008. View Article : Google Scholar

36 

Dai HP, Xue YQ, Wu LL, Pan JL, Gong YL, Wu YF, Zhang J, Wu DP and Chen SN: p210BCR-ABLas a secondary change in a patient with acute myelomonocytic leukemia(M4Eo) with inv(16). Int J Hematol. 96:814–817. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang YY, Ding WJ, Jiang F, Chen ZX, Cen JN, Qi XF, Liang JY, Liu DD, Pan JL, Chen SN, Chen SN, et al: Coexistence of p210BCR‑ABL and CBFβ‑MYH11 fusion genes in myeloid leukemia: A report of 4 cases. Oncol Lett 14: 5171-5178, 2017.
APA
Wang, Y., Ding, W., Jiang, F., Chen, Z., Cen, J., Qi, X. ... Chen, S. (2017). Coexistence of p210BCR‑ABL and CBFβ‑MYH11 fusion genes in myeloid leukemia: A report of 4 cases. Oncology Letters, 14, 5171-5178. https://doi.org/10.3892/ol.2017.6812
MLA
Wang, Y., Ding, W., Jiang, F., Chen, Z., Cen, J., Qi, X., Liang, J., Liu, D., Pan, J., Chen, S."Coexistence of p210BCR‑ABL and CBFβ‑MYH11 fusion genes in myeloid leukemia: A report of 4 cases". Oncology Letters 14.5 (2017): 5171-5178.
Chicago
Wang, Y., Ding, W., Jiang, F., Chen, Z., Cen, J., Qi, X., Liang, J., Liu, D., Pan, J., Chen, S."Coexistence of p210BCR‑ABL and CBFβ‑MYH11 fusion genes in myeloid leukemia: A report of 4 cases". Oncology Letters 14, no. 5 (2017): 5171-5178. https://doi.org/10.3892/ol.2017.6812
Copy and paste a formatted citation
x
Spandidos Publications style
Wang YY, Ding WJ, Jiang F, Chen ZX, Cen JN, Qi XF, Liang JY, Liu DD, Pan JL, Chen SN, Chen SN, et al: Coexistence of p210BCR‑ABL and CBFβ‑MYH11 fusion genes in myeloid leukemia: A report of 4 cases. Oncol Lett 14: 5171-5178, 2017.
APA
Wang, Y., Ding, W., Jiang, F., Chen, Z., Cen, J., Qi, X. ... Chen, S. (2017). Coexistence of p210BCR‑ABL and CBFβ‑MYH11 fusion genes in myeloid leukemia: A report of 4 cases. Oncology Letters, 14, 5171-5178. https://doi.org/10.3892/ol.2017.6812
MLA
Wang, Y., Ding, W., Jiang, F., Chen, Z., Cen, J., Qi, X., Liang, J., Liu, D., Pan, J., Chen, S."Coexistence of p210BCR‑ABL and CBFβ‑MYH11 fusion genes in myeloid leukemia: A report of 4 cases". Oncology Letters 14.5 (2017): 5171-5178.
Chicago
Wang, Y., Ding, W., Jiang, F., Chen, Z., Cen, J., Qi, X., Liang, J., Liu, D., Pan, J., Chen, S."Coexistence of p210BCR‑ABL and CBFβ‑MYH11 fusion genes in myeloid leukemia: A report of 4 cases". Oncology Letters 14, no. 5 (2017): 5171-5178. https://doi.org/10.3892/ol.2017.6812
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team